CELCUITY INC. Convertible Notes Payable
CELCUITY INC. (CELC) had Convertible Notes Payable of $130.00 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2026-08-13
- 2026-03-31: Convertible Notes Payable $130.00M.
- 2025-12-31: Convertible Notes Payable $130.00M.
- 2025-09-30: Convertible Notes Payable $130.00M.
- 2025-06-30: Convertible Notes Payable $100.00M.
| Period end | Convertible Notes Payable |
|---|---|
| 2026-03-31 | $130.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $130.00M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $130.00M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $100.00M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $100.00M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $100.00M 10-K · filed 2026-03-26 |
| 2024-09-30 | $100.00M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $100.00M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $35.00M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $35.00M 10-K · filed 2025-03-31 |
| 2023-09-30 | $35.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $35.00M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $35.00M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $35.00M 10-K · filed 2024-03-27 |
| 2022-09-30 | $15.00M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $15.00M 10-K · filed 2023-03-23 |
| 2021-09-30 | $15.00M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $15.00M 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |